New Jersey’s Careful Approach to Cannabis: Part Two
Click here to read Part One where we examined the state of the market, licensing, approvals and sales. Part Two delves into […]
Month: February 2023
Study: Current, Lifetime Cannabis Use Associated with Lower Blood Pressure
Among the myriad benefits cannabis can offer, it looks like the plant medicine may be linked to lower blood pressure levels. According […]
Rhode Island Bill To Criminalize Cannabis Use In Groups Of Three Or More People Is Being Rewritten, Sponsor Says
Marijuana Moment reports A controversial bill filed in Rhode Island earlier this month would make it illegal to have cannabis at gatherings […]
Oklahoma AG to Prosecute Attorney Accused of ‘Ghost Owner’ Medical Cannabis Scheme
Ganjapreneur reports The Oklahoma Attorney General’s office is taking over the prosecution of the attorney accused of helping set up illegal cannabis businesses under […]
KEENAN M. JONES JOINS FRANTZ WARD’S CANNABIS PRACTICE GROUP
Frantz Ward is pleased to announce that Keenan M. Jones has joined the firm, Of Counsel, in its Cannabis Practice Group. Keenan represents businesses of […]
New Title: Should All Drugs Be Legalized? Published by Thames & Hudson
The Big Idea series looks at the use of drugs in human society in this timely reexamination of the debate over the […]
New Jersey Supreme Court sides with drug offenders in new test of cannabis legalization law
The New Jersey Monitor reports People who dodged conviction for minor drug offenses through a diversionary program for first-time offenders before state […]
New Jersey’s Careful Approach to Cannabis: Part One
This is Part One where we examine the state of the market, licensing, approvals and sales. Part Two will delve into all things […]
CBD May Magnify Effects of THC in Edibles, Johns Hopkins Study Suggests
According to a study published Feb. 13 in JAMA Network Open, when THC was combined with CBD in edibles, they produced significantly […]
DEA Says Novel Cannabinoids Including Delta-9 THCO Are Illegal
The DEA disclosed in a letter this week that it considers products containing novel cannabinoids such as Delta-9 and Delta-8 THCO, also known as […]